Company profile ETON

Eton Pharmaceuticals Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 22:27:08.

After 39 days of this quarter the interest is at 104.0. Based on that we can calculate that during remaining 52 days it will total up to 243.0.
Eton Pharmaceuticals expected interest is significantly higher compared to previous quarter (+341.8%) and same quarter last year (+767.9%).

YearQ1Q2Q3Q4
201938
33
-13.2% QoQ
74
124.2% QoQ
54
-27.0% QoQ
2020 45
18.4% YoY -16.7% QoQ
51
54.5% YoY 13.3% QoQ
265
258.1% YoY 419.6% QoQ
80
48.1% YoY -69.8% QoQ
2021 32
-28.9% YoY -60.0% QoQ
102
100.0% YoY 218.8% QoQ
60
-77.4% YoY -41.2% QoQ
30
-62.5% YoY -50.0% QoQ
2022 60
87.5% YoY 100.0% QoQ
38
-62.7% YoY -36.7% QoQ
45
-25.0% YoY 18.4% QoQ
34
13.3% YoY -24.4% QoQ
2023 28
-53.3% YoY -17.6% QoQ
20
-47.4% YoY -28.6% QoQ
38
-15.6% YoY 90.0% QoQ
55
61.8% YoY 44.7% QoQ
2024 104
271.4% YoY 89.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Eton Pharmaceuticals search interestLast update: February 08 2024 22:27:07.
Correlation coefficient between keyword and revenue is -0.78
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:27:09.

The average 5 years interest of Eton Pharmaceuticals was 4.93 per week.
The last year interest of Eton Pharmaceuticals compared to the last 5 years has changed by -6.69%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 7.73%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Eton Pharmaceuticals ALKINDI SPRINKLE to provide analysis

Correlation between past revenue and Eton Pharmaceuticals ALKINDI SPRINKLE search interest

There is not enough data for Eton Pharmaceuticals ALKINDI SPRINKLE to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Eton Pharmaceuticals ALKINDI SPRINKLE to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Eton Pharmaceuticals Carglumic Acid to provide analysis

Correlation between past revenue and Eton Pharmaceuticals Carglumic Acid search interest

There is not enough data for Eton Pharmaceuticals Carglumic Acid to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Eton Pharmaceuticals Carglumic Acid to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Eton Pharmaceuticals Betaine Anhydrous to provide analysis

Correlation between past revenue and Eton Pharmaceuticals Betaine Anhydrous search interest

There is not enough data for Eton Pharmaceuticals Betaine Anhydrous to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Eton Pharmaceuticals Betaine Anhydrous to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Eton Pharmaceuticals dehydrated alcohol injection to provide analysis

Correlation between past revenue and Eton Pharmaceuticals dehydrated alcohol injection search interest

There is not enough data for Eton Pharmaceuticals dehydrated alcohol injection to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Eton Pharmaceuticals dehydrated alcohol injection to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Eton Pharmaceuticals Zeno hydrocortisone autoinjector to provide analysis

Correlation between past revenue and Eton Pharmaceuticals Zeno hydrocortisone autoinjector search interest

There is not enough data for Eton Pharmaceuticals Zeno hydrocortisone autoinjector to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Eton Pharmaceuticals Zeno hydrocortisone autoinjector to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Eton Pharmaceuticals Alaway Preservative Free to provide analysis

Correlation between past revenue and Eton Pharmaceuticals Alaway Preservative Free search interest

There is not enough data for Eton Pharmaceuticals Alaway Preservative Free to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Eton Pharmaceuticals Alaway Preservative Free to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Eton Pharmaceuticals EPRONTIA to provide analysis

Correlation between past revenue and Eton Pharmaceuticals EPRONTIA search interest

There is not enough data for Eton Pharmaceuticals EPRONTIA to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Eton Pharmaceuticals EPRONTIA to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Eton Pharmaceuticals ZONISADE to provide analysis

Correlation between past revenue and Eton Pharmaceuticals ZONISADE search interest

There is not enough data for Eton Pharmaceuticals ZONISADE to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Eton Pharmaceuticals ZONISADE to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Eton Pharmaceuticals Lamotrigine for Oral Suspension to provide analysis

Correlation between past revenue and Eton Pharmaceuticals Lamotrigine for Oral Suspension search interest

There is not enough data for Eton Pharmaceuticals Lamotrigine for Oral Suspension to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Eton Pharmaceuticals Lamotrigine for Oral Suspension to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ETON
Earnings date: 2024-03-11 After close
Company name: Eton Pharmaceuticals Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-14T20:05:00Z

GlobeNewswire
Eton Pharmaceuticals Reports First Quarter 2026 Financial Results

2026-05-12T20:30:00Z

GlobeNewswire
Eton Pharmaceuticals to Participate in Upcoming Investor Conferences

2026-05-04T20:30:00Z

GlobeNewswire
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

2026-05-01T10:50:00Z

GlobeNewswire
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution

2026-04-27T10:50:00Z

GlobeNewswire
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700

2026-04-24T16:05:36-04:00

SEC
DEF 14A Form - Other definitive proxy statements - Eton Pharmaceuticals, Inc. (0001710340) (Filer)

2026-04-16T10:50:00Z

GlobeNewswire
Eton Pharmaceuticals Announces CFO Succession Plan

2026-03-20T17:57:02Z

Analyst Upgrades
B. Riley Securities Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $31

2026-03-20T17:44:19Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $52

2026-03-20T17:15:57Z

Analyst Upgrades
Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $35

2026-03-03T21:30:00Z

GlobeNewswire
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026

2026-03-03T14:45:04Z

Analyst Upgrades
Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $30

2026-03-02T12:45:58Z

Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $37

2026-03-02T12:27:44Z

GlobeNewswire
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution

2026-02-25T18:47:00Z

GlobeNewswire
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution